YH
Highly rated in
27
conditions

Dr. Ying J. Hitchcock

University Of Utah Adult Services
Salt Lake City, UT
Highly rated in
27
conditions
Specialties:Radiation Oncology
Experience:38 Years
Clinical Trials:Currently Recruiting for 2 Trials
Accepts:New PatientsMedicare
Highly rated in
27
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Ying J. Hitchcock's experience treating your condition:
About Dr. Ying J. Hitchcock

Ying Hitchcock is a Radiation Oncologist in Salt Lake City, Utah. Hitchcock has been practicing medicine for over 38 years and is highly rated in 27 conditions, according to our data. Her top areas of expertise are Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, Tongue Cancer, Salivary Gland Tumors, and Gamma Knife Radiosurgery. She is licensed to treat patients in Utah. Hitchcock is currently accepting new patients.

Her clinical research consists of co-authoring 68 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Ying J. Hitchcock it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Ying J. Hitchcock accepts the following insurance:

  •  Ambetter
  •  Molina Healthcare
  •  Montana Health Cooperative
  •  Regence
  •  University of Utah Health
  •  BridgeSpan
Locations
Salt Lake City, UT 84112
Background & Education
Graduate Institution
Other, 1985
Specialties
Radiation Oncology
Licenses
Radiology in UT
Hospital Affiliations
University Of Utah Hospital
Primary Childrens Hospital
George E Wahlen Department Of Veterans Affairs Medical Center
Languages Spoken
English
Chinese
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Enrollment Status: Recruiting
Publish Date: December 14, 2022
Intervention Type: Other, Drug, Radiation, Biological
Study Drugs: AtezolizumabCetuximabCisplatinDocetaxel
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Recruiting
Publish Date: December 08, 2022
Intervention Type: Other, Drug, Biological, Radiation
Study Drugs: CisplatinNivolumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active, not recruiting
Publish Date: November 02, 2022
Intervention Type: Other, Radiation
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active, not recruiting
Publish Date: October 27, 2022
Intervention Type: Radiation, Biological
Study Drug: Cetuximab
Study Phase: Phase 3
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Enrollment Status: Active, not recruiting
Publish Date: October 19, 2022
Intervention Type: Drug, Radiation, Procedure
Study Drugs: DoxorubicinIfosfamidePazopanib
Study Phase: Phase 2/Phase 3
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Enrollment Status: Active, not recruiting
Publish Date: September 21, 2022
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
Enrollment Status: Completed
Publish Date: June 10, 2022
Intervention Type: Drug, Other, Radiation, Biological
Study Drugs: CisplatinPembrolizumab
Study Phase: Phase 1
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Enrollment Status: Completed
Publish Date: April 24, 2020
Intervention Type: Radiation
Study Phase: Not Applicable
View 6 Less Clinical Trials -
68 Total Publications
Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel.
Journal: Practical radiation oncology
Published: April 28, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
DG
Dr. David K. Gaffney
Radiation Oncology
Highly rated in
7
conditions
Radiation Oncology

University of Utah Health

Huntsman Cancer Institute

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 0.1 mi

David Gaffney is a Radiation Oncologist in Salt Lake City, Utah. Gaffney has been practicing medicine for over 31 years and is highly rated in 7 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Cervical Cancer, and Vaginal Cancer. He is licensed to treat patients in Utah. Gaffney is currently accepting new patients.

DS
Dr. Dennis C. Shrieve
Radiation Oncology
Highly rated in
10
conditions
Radiation Oncology

University of Utah Health

Huntsman Cancer Hospital

1950 Circle Of Hope Dr, 
Salt Lake City, UT 
 0.1 mi

Dennis Shrieve is a Radiation Oncologist in Salt Lake City, Utah. Shrieve has been practicing medicine for over 34 years and is highly rated in 10 conditions, according to our data. His top areas of expertise are Metastatic Brain Tumor, Brain Tumor, Radiation Induced Meningioma, Gamma Knife Radiosurgery, and Prostatectomy. He is licensed to treat patients in Massachusetts and Utah. Shrieve is currently accepting new patients.

LB
Dr. Lindsay M. Burt
Radiation Oncology
Highly rated in
15
conditions
Radiation Oncology

University of Utah Health

Huntsman Cancer Hospital

1950 Cir Of Hope Dr, 
Salt Lake City, UT 
 0.1 mi

Lindsay Burt is a Radiation Oncologist in Salt Lake City, Utah. Burt has been practicing medicine for over 12 years and is highly rated in 15 conditions, according to our data. Her top areas of expertise are Meningioma, Glioma, Oligodendroglioma, and Atypical Teratoid Rhabdoid Tumor (ATRT). She is licensed to treat patients in Utah. Burt is currently accepting new patients.